Online ISSN: 2577-5669
-
Development of Telmisartan 40 mg Tablets with Improved Bioavailability Using Solid Dispersion Technique
Volume 17 | Issue 1
-
Design and optimization of Glibenclamide -nanoemulsion Technology for Enhanced Drug Delivery
Volume 17 | Issue 1
-
Formulation and evaluation of nano emulsion of aceclofenac (100mg) for enhanced solubility and dissolution rate
Volume 17 | Issue 1
-
Development of Controlled Release Matrix Tablets using Natural Polymers
Volume 17 | Issue 1
-
Evolution of Drug Regulatory Guidelines in the Era of Globalization
Volume 17 | Issue 1
Development of Telmisartan 40 mg Tablets with Improved Bioavailability Using Solid Dispersion Technique
Main Article Content
Abstract
Telmisartan, a widely used angiotensin II receptor blocker for the management of hypertension, belongs to the Biopharmaceutics Classification System (BCS) Class II and is characterized by low aqueous solubility and variable oral bioavailability
